• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

New for 2017!
Filter
Title Search
1 - 25 of 170 Products Sort by Display
Sleep Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564941
Published
September 26, 2017
Content info
76 Pages
Price
USD 3995
Sample available
Pneumonia Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564940
Published
September 26, 2017
Content info
123 Pages
Price
USD 3995
Sample available
Male Health Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564939
Published
September 25, 2017
Content info
125 Pages
Price
USD 3995
Sample available
Colorectal Cancer Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564938
Published
September 22, 2017
Content info
299 Pages
Price
USD 3995
Sample available
Behavioral Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564937
Published
September 14, 2017
Content info
113 Pages
Price
USD 3995
Sample available
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
Published by
GBI Research
Product code
563402
Published
September 1, 2017
Content info
135 Pages
Price
USD 6995
Sample available
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
Published by
GBI Research
Product code
563401
Published
September 1, 2017
Content info
155 Pages
Price
USD 4995
Sample available
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
Published by
GBI Research
Product code
550298
Published
August 1, 2017
Content info
113 Pages
Price
USD 6995
Sample available
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape
Published by
GBI Research
Product code
550297
Published
August 1, 2017
Content info
138 Pages
Price
USD 4995
Sample available
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape
Published by
GBI Research
Product code
550296
Published
August 1, 2017
Content info
132 Pages
Price
USD 4995
Sample available
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
Published by
GBI Research
Product code
550295
Published
August 1, 2017
Content info
79 Pages
Price
USD 6995
Sample available
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537172
Published
August 1, 2017
Content info
254 Pages
Price
USD 3995
Sample available
Hepatitis Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537171
Published
August 1, 2017
Content info
209 Pages
Price
USD 3995
Sample available
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537170
Published
August 1, 2017
Content info
138 Pages
Price
USD 3995
Sample available
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis
Published by
GBI Research
Product code
540334
Published
July 1, 2017
Content info
136 Pages
Price
USD 4995
Sample available
Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Published by
GBI Research
Product code
531729
Published
July 1, 2017
Content info
 
Price
USD 2995
Sample available
Transplantation Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524529
Published
July 1, 2017
Content info
242 Pages
Price
USD 3995
Sample available
Skeletal Disease Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524528
Published
July 1, 2017
Content info
176 Pages
Price
USD 3995
Sample available
Pain Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524527
Published
July 1, 2017
Content info
229 Pages
Price
USD 3995
Sample available
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
318827
Published
July 1, 2017
Content info
143 Pages
Price
USD 4995
Sample available
Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors
Published by
GBI Research
Product code
530489
Published
June 13, 2017
Content info
420 Pages
Price
USD 4995
Sample available
Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation
Published by
GBI Research
Product code
524531
Published
June 1, 2017
Content info
98 Pages
Price
USD 6995
Sample available
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse
Published by
GBI Research
Product code
524530
Published
June 1, 2017
Content info
147 Pages
Price
USD 4995
Sample available
Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market
Published by
GBI Research
Product code
520763
Published
June 1, 2017
Content info
134 Pages
Price
USD 4995
Sample available
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Product code
326290
Published
June 1, 2017
Content info
70 Pages
Price
USD 6995
Sample available